LataMed AI is trading 10.96% up at $0.40 after announcing on August 19, 2026, that its mobile healthcare application entered final testing, optimization, and deployment preparation.
- Management expects to submit the application to Apple’s App Store and Google Play in the coming weeks, subject to platform review and technical requirements.
- The company-specific catalyst is supporting the gain despite weaker broader equity and healthcare-sector sentiment on August 20, 2026.